Wan‐Long Chuang

23.4k total citations · 1 hit paper
513 papers, 11.1k citations indexed

About

Wan‐Long Chuang is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Wan‐Long Chuang has authored 513 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 392 papers in Hepatology, 378 papers in Epidemiology and 43 papers in Surgery. Recurrent topics in Wan‐Long Chuang's work include Hepatitis C virus research (324 papers), Liver Disease Diagnosis and Treatment (318 papers) and Hepatitis B Virus Studies (248 papers). Wan‐Long Chuang is often cited by papers focused on Hepatitis C virus research (324 papers), Liver Disease Diagnosis and Treatment (318 papers) and Hepatitis B Virus Studies (248 papers). Wan‐Long Chuang collaborates with scholars based in Taiwan, United States and China. Wan‐Long Chuang's co-authors include Ming‐Lung Yu, Chia‐Yen Dai, Zu‐Yau Lin, Jee‐Fu Huang, Liang‐Yen Wang, Wen‐Yu Chang, Chung‐Feng Huang, Shinn‐Cherng Chen, Ming‐Yuh Hsieh and Ming‐Yen Hsieh and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Wan‐Long Chuang

499 papers receiving 10.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

2012 834 citations Jia‐Horng Kao, Henry Lik‐Yuen Chan et al. profile →

Peers

Countries citing papers authored by Wan‐Long Chuang

Since Specialization

Citations

This map shows the geographic impact of Wan‐Long Chuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan‐Long Chuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan‐Long Chuang more than expected).

Fields of papers citing papers by Wan‐Long Chuang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan‐Long Chuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan‐Long Chuang. The network helps show where Wan‐Long Chuang may publish in the future.

Co-authorship network of co-authors of Wan‐Long Chuang

This figure shows the co-authorship network connecting the top 25 collaborators of Wan‐Long Chuang. A scholar is included among the top collaborators of Wan‐Long Chuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan‐Long Chuang. Wan‐Long Chuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and Safety of Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) Followed by TAF in Chronic Hepatitis B Patients of East Asian Ethnicity Following 5 Years of Treatment 2025 ·Alimentary Pharmacology & Therapeutics ·Grace Lai–Hung Wong, Edward Gane, Calvin Q. Pan, Scott Fung, Mang Ma, Namiki Izumi, S. Shalimar, Seng Gee Lim, Wan‐Long Chuang, (unknown), Young‐Suk Lim, Leland J. Yee, John F. Flaherty, (unknown), Hongyuan Wang, Marı́a Buti	0
2	Surveillance Imaging and GAAD/GALAD Scores for Detection of Hepatocellular Carcinoma in Patients with Chronic Hepatitis 2024 ·Journal of Clinical and Translational Hepatology ·Chung‐Feng Huang, (unknown), Chih‐Wen Wang, Tyng‐Yuan Jang, Ming‐Lun Yeh, Po‐Cheng Liang, Yu‐Ju Wei, Po‐Yao Hsu, Ching‐I Huang, Ming‐Yen Hsieh, Yi‐Hung Lin, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, (unknown), Ming‐Lung Yu	4
3	Performance of noninvasive seromarkers in predicting liver fibrosis among MAFLD patients with or without viral hepatitis 2024 ·The Kaohsiung Journal of Medical Sciences ·Chung‐Feng Huang, Po‐Cheng Liang, Chih‐Wen Wang, Tyng‐Yuan Jang, Po‐Yao Hsu, Pei‐Chien Tsai, Yu‐Ju Wei, Ming‐Lun Yeh, Ming‐Yen Hsieh, Yi‐Hung Lin, Chao‐Kuan Huang, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu	3
4	Chronic Hepatitis C Related Steatotic Liver Disease Is More Than “Miscellaneous Steatotic Liver Disease” 2024 ·Clinical Gastroenterology and Hepatology ·Chung‐Feng Huang, (unknown), Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu	5
5	Phase Ib/IIa randomized study of heterologous ChAdOx1-HBV/MVA-HBV therapeutic vaccination (VTP-300) as monotherapy and combined with low-dose nivolumab in virally-suppressed patients with CHB 2024 ·Journal of Hepatology ·Won Young Tak, Wan‐Long Chuang, Chi-Yi Chen, Kuo‐Chih Tseng, Young‐Suk Lim, Gin‐Ho Lo, Jeong Heo, Kosh Agarwal, (unknown), (unknown), (unknown), Anthony Brown, Katie Anderson, Antonella Vardeu, (unknown), Jakub Kopycinski, (unknown), Eleanor Barnes, Thomas G. Evans	17
6	Air pollution associate with advanced hepatic fibrosis among patients with chronic liver disease 2023 ·The Kaohsiung Journal of Medical Sciences ·Tyng‐Yuan Jang, (unknown), Po‐Cheng Liang, (unknown), Yu‐Ju Wei, Pei‐Chien Tsai, Po‐Yao Hsu, Ming‐Yen Hsieh, Yi‐Hung Lin, Meng‐Hsuan Hsieh, (unknown), Jeng‐Fu Yang, Ming‐Lun Yeh, Chung‐Feng Huang, Wan‐Long Chuang, Jee‐Fu Huang, (unknown), Chia‐Yen Dai, Pau‐Chung Chen, Ming‐Lung Yu	10
7	Effects of Achieving SVR on Clinical Characteristics and Surgical Outcomes in Patients Who Developed Early-Stage HCV-Related Hepatocellular Carcinoma and Received Curative Resection: Preoperative versus Postoperative SVR 2022 ·Viruses ·Po‐Yao Hsu, Po‐Cheng Liang, Ching‐I Huang, Meng‐Hsuan Hsieh, Yi‐Shan Tsai, Tzu-Chun Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Chih‐Wen Wang, Tyng‐Yuan Jang, Yi‐Hung Lin, Zu‐Yau Lin, Wan‐Long Chuang, Chia‐Yen Dai	3
8	The Prevalence and Serological Association of Hepatitis D Virus Genotypes in Taiwan 2021 ·Pathogens ·(unknown), (unknown), Tyng‐Yuan Jang, Chung‐Feng Huang, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Ming‐Lung Yu, Shu‐Chi Wang	1
9	The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression 2021 ·Biomedicines ·(unknown), (unknown), Chia‐Yang Li, Wei‐Chung Cheng, (unknown), Chung‐Feng Huang, Ming‐Lun Yeh, Chia‐Yen Dai, Jee‐Fu Huang, Wan‐Long Chuang, Zu‐Yau Lin, Ming‐Lung Yu, Shu‐Chi Wang	4
10	Real‐world effectiveness of direct‐acting antiviral agents for chronic hepatitis C patients with genotype‐2 infection after completed treatment 2020 ·The Kaohsiung Journal of Medical Sciences ·(unknown), Po‐Cheng Liang, Chung‐Feng Huang, Ming‐Lun Yeh, Ching‐I Huang, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, (unknown), Wan‐Long Chuang, Ming‐Lung Yu	7
11	Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence 2020 ·Liver International ·Shu‐Chi Wang, Chia‐Yang Li, Wen‐Tsan Chang, Wei‐Chung Cheng, Chia‐Hung Yen, (unknown), Zu‐Yau Lin, Ching‐Chih Lin, Ming‐Lun Yeh, Chung‐Feng Huang, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang, Yao‐Li Chen, Ming‐Lung Yu	22
12	Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health‐related quality of life in East Asian patients with hepatitis C virus infection 2018 ·Journal of Viral Hepatitis ·Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang‐Hyub Han, Sang Hoon Ahn, Young‐Suk Lim, Wan‐Long Chuang, Jia‐Horng Kao, Kinh Van Nguyen, Ching‐Lung Lai, Henry Lik‐Yuen Chan, Lai Wei	14
13	The effect of interferon‐free regimens on health‐related quality of life in East Asian patients with chronic hepatitis C 2017 ·Liver International ·Zobair M. Younossi, Maria Stepanova, Linda Henry, Kwang‐Hyub Han, Sang Hoon Ahn, Young‐Suk Lim, Wan‐Long Chuang, Jia‐Horng Kao, (unknown), Ching‐Lung Lai, Man‐Fung Yuen, Henry Lik‐Yuen Chan, Lai Wei	18
14	Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment 2016 ·Clinical Cancer Research ·Ming‐Lung Yu, Chung‐Feng Huang, Ming‐Lun Yeh, Pei‐Chien Tsai, Ching‐I Huang, Meng‐Hsuan Hsieh, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang	26
15	A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection 2016 ·Liver International ·Jia‐Horng Kao, Rong‐Nan Chien, Ting‐Tsung Chang, Cheng‐Yuan Peng, Tsung‐Hui Hu, Gin‐Ho Lo, Horng‐Yuan Wang, (unknown), Jenny C. Yang, Steven Knox, Lingling Han, Hongmei Mo, Anita Mathias, Diana M. Brainard, I‐Shyan Sheen, Yu‐Chun Hsu, Chi‐Jen Chu, Wan‐Long Chuang	22
16	Ledipasvir/sofosbuvir fixed‐dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus 2016 ·Journal of Gastroenterology and Hepatology ·Wan‐Long Chuang, Rong‐Nan Chien, Cheng‐Yuan Peng, Ting‐Tsung Chang, Gin‐Ho Lo, I‐Shyan Sheen, Horng‐Yuan Wang, (unknown), Jenny C. Yang, Steven Knox, Bing Gao, Kimberly L. Garrison, Hongmei Mo, Phillip S. Pang, Yu‐Chun Hsu, Tsung‐Hui Hu, Chi‐Jen Chu, Jia‐Horng Kao	22
17	Chronic hepatitis C infection is associated with insulin resistance and lipid profiles 2013 ·Journal of Gastroenterology and Hepatology ·Chia‐Yen Dai, Ming‐Lun Yeh, Chung‐Feng Huang, (unknown), Ming‐Yen Hsieh, Jee‐Fu Huang, I‐Ling Lin, Zu‐Yau Lin, Shinn‐Chern Chen, Liang‐Yen Wang, Wan‐Long Chuang, Ming‐Lung Yu, Hung‐Da Tung	54
18	Hepatic Steatosis and Fibrosis in Chronic Hepatitis C in Taiwan 2007 ·Japanese Journal of Infectious Diseases ·Meng‐Hsuan Hsieh, Li‐Po Lee, Ming‐Yen Hsieh, Kun‐Bow Tsai, Jee‐Fu Huang, Nai‐Jen Hou, Shinn‐Chern Chen, Zu‐Yau Lin, Ming‐Yuh Hsieh, Liang‐Yen Wang, Chia‐Yen Dai, Wan‐Long Chuang, Ming‐Lung Yu	22
19	Prevalence and Clinical Significance of HGV/GBV-C Infection in Patients with Chronic Hepatitis B or C 2006 ·Japanese Journal of Infectious Diseases ·Jeng‐Fu Yang, Chia‐Yen Dai, Wan‐Long Chuang, Wen‐Yi Lin, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Jung‐Fa Tsai, Wen‐Yu Chang, Ming‐Lung Yu	19
20	Abdominal sonographic screening in a single community. 1990 ·PubMed ·Sheng‐Nan Lu, Liang‐Yen Wang, Wen‐Yu Chang, Chien‐Jen Chen, (unknown), (unknown), Wan‐Long Chuang, Ming‐Yuh Hsieh	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact